North America Maintains Leadership in the Human Microbiome Therapeutics Market with Strong FDA Support
The global human microbiome therapeutics market, valued at USD 1.01 billion in 2024, is poised for significant expansion, projected to grow at a CAGR of 22.80% from 2025 to 2034. This growth is driven by increasing recognition of the microbiome's role in health, advancements in next-generation sequencing technologies, and rising prevalence of microbiome-related diseases. Regionally, North...
0 Comments 0 Shares 726 Views 0 Reviews